Evidence map›Paper›PMID 36982205›Full record

ArticleInternational journal of molecular sciences2023

In Vitro Antiviral and Anti-Inflammatory Activities of

Magda Marchetti, Barbara De Berardis, Irene Bigioni, Alessia Mariano, Fabiana Superti, Anna Scotto d'Abusco

Open access · goldFull text read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Immunomodulatory Effects ofInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Modulation of Plet1 expression by N-Acetylglucosamine through the IL-17 A-MAPK pathway in an imiquimod-induced psoriasis mouse model.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Magda MarchettiNational Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0003-3871-4976
Barbara De BerardisNational Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0001-7857-9620
Irene BigioniDepartment of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-1093-7764
Alessia MarianoDepartment of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9569-8952
Fabiana SupertiNational Centre for Innovative Technologies in Public Health, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy.ORCID 0000-0003-4909-7598
Anna Scotto d'AbuscoDepartment of Biochemical Sciences, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-3323-6015
Istituto Superiore di Sanità · ITSapienza University of Rome · IT

Funding

Progetto POR FESR LAZIO-2014-2020 A0375-2020-36535
6 · The paper itself

Abstract

Viral respiratory tract infections (RTIs) are responsible for significant morbidity and mortality worldwide. A prominent feature of severe respiratory infections, such as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is the cytokine release syndrome. Therefore, there is an urgent need to develop different approaches both against viral replication and against the consequent inflammation.

Indexed as

COVID-19Influenza A virusInfluenza A Virus, H1N1 SubtypePneumoniaRespiratory Tract InfectionsVirus DiseasesAcetylglucosamineAdenoviridaeAnti-Inflammatory AgentsAntiviral AgentsGlucosamineHumansSARS-CoV-2AcetylglucosamineAnti-Inflammatory AgentsAntiviral AgentsGlucosamineadenovirusinflammationInfluenza A virusN-acetylglucosaminenanotechnologyviral respiratory infections

Identifiers

PMID36982205
PMCPMC10049122
OpenAlexW4323566335

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read58
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.